J

JM Research | JM Research SC

Research site
(Unclaimed)
Location
Avenida Teopanzolco 217, Suite 2 Colonia Vista Hermosa, Cuernavaca, Morelos, Mexico
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 16
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis (MAESTRO-NASH)

A double-blind placebo controlled randomized Phase 3 study to determine if 80 or 100 mg of MGL-3196 as compared with placebo resolves NASH and/or red...

Active, not recruiting
NASH - Nonalcoholic Steatohepatitis
Drug: Placebo
Drug: MGL-3196

The study consists of 4 sub-studies, as follows:Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safety...

Active, not recruiting
Crohn's Disease
Drug: Risankizumab SC
Drug: Risankizumab On-Body Injector (OBI)

The purpose of this study is to evaluate safety and efficacy of risankizumab in participants with ulcerative colitis (UC) in participants who respond...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: risankizumab
Drug: placebo for risankizumab

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 100 mg
Drug: Placebo

Trial conditions

COVID-19 (6 trials)
Crohn Disease (3 trials)
Atopic Dermatitis (2 trials)
Colitis (2 trials)
Dermatitis (2 trials)
Eczema (2 trials)
Fatty Liver (2 trials)
Non-alcoholic Fatty Live... (2 trials)
Ulcer (2 trials)
Ulcerative Colitis (2 trials)

And 12 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems